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Abstract
Prostate cancer (PCa) is one of the leading causes of mortality in men. Current 
therapeutics for PCa are androgen depletion by castration or/and anti-androgen based 
treatments. Androgens are necessary for Androgen receptor (AR) to function as a 
transcription factor, AR then regulates the expression of genes which promote cancer 
cell proliferation. However, despite the therapeutic interventions recurred AR 
signaling, which is facilitated by the acquisition of mutations in AR and its 
amplification, cholesterol biosynthesis and alterations in the steroidogenesis continue 
promoting PCa carcinogenesis. Our research is focused on regulatory small RNA 
molecules know as microRNAs (miRNA) in PCa. Numerous miRNAs fine-tune the 
expression of multiple genes involved in posttranslational modification, cell 
proliferation, organogenesis, energy balancing and developmental regulation thus 
affecting cell proliferation, differentiation, and cell death. miRNA “replacement 
therapy” is highly promising as it can target the expression of carcinogenesis 
promoting AR and androgen signaling, the holy grail of PCa therapeutics. In this 
research project, we have tested the efficiency of miR-149-5p in controlling AR 
expression using a sensor luciferase reporter assay system in PCa cell culture model. 
We found a significant downregulation of AR reporter gene in PCa cells indicating 
the efficacy of miR-149-5p in controlling the growth of AR based tumors. Our result 
indicates miRNA mediated regulation of genes involved in PCa and therapeutic 
potential.
